| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | 54.7× | −1.7× | |
| Price / Book | 8.5× | 2.0× | |
| Price / Sales | 8.8× | 3.9× | |
| Price / Free cash flow | 57.6× | −1.6× | |
| EV / EBITDA | 36.8× | −1.2× | |
| Earnings yield | 1.8% | −14.6% | |
| Free cash flow yield | 1.7% | −9.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,241.71 | −1.22% | $1.17T | 57.3× | 77.8% | +16.7% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $253.90 | −0.65% | $611.87B | 23.0× | 32.9% | +33.7% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $282.88 | −0.89% | $499.88B | 119.3× | −129.2% | +26.2% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $406.68 | +1.31% | $365.03B | 29.9× | 12.8% | +11.2% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $143.58 | −1.62% | $354.24B | 19.7× | 34.7% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $150.18 | −0.30% | $277.81B | 19.8× | 30.5% | +15.9% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $163.96 | −0.88% | $254.29B | 25.0× | 21.1% | −2.2% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $679.58 | −1.51% | $251.27B | 37.9× | 12.6% | +30.7% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $424.91 | −1.75% | $229.72B | 30.3× | 89.1% | +45.5% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $153.12 | −1.97% | $189.86B | 22.8× | 37.5% | +32.0% |
